Recent Updates
Recently added Catalysts
PRPO

Precipio Announces Third Quarter Shareholder Update Call Conference Call to be held on Monday, November 14 th , 202 2 at 5:00 PM ET NEW HAVEN, CT, Globenewswire - (November 2 nd , 2022) - Specialty cancer diagnostics com

Key Takeaway: Third Quarter Shareholder Update Call Call to be held on Monday, November 14th, 2022 at 5:00 PM ET HAVEN, CT, Globenewswire - (November 2nd, 2022) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q3-2022 shareholder update call on Monda

Full Press Release Details

Third Quarter Shareholder Update Call
Call to be held on Monday, November 14th, 2022 at 5:00 PM ET
HAVEN, CT, Globenewswire - (November 2nd, 2022) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:
PRPO), will be hosting its Q3-2022 shareholder update call on Monday, November 14th
at 5:00 PM ET. The call will include updates on the Company's current core businesses.
The conference call may be accessed
by calling 844-695-5519 (international callers dial 1-412-902-6760). All callers should ask for the Precipio Inc. conference call. Participants
may also pre-register for the conference call at https://dpregister.com/sreg/10173003/f504ba2427.
For those that pre-register for the shareholder call, the host service will send a calendar invitation and a direct dial-in number
for the call to your email used during registration, which will allow for the registrant to bypass the operator.
interested in submitting questions in advance should email their questions to investors@precipiodx.com and
management will do its best to address those questions during the call.
replay of the call will be available approximately 24 hours after the call and may be accessed via the investors page located on
a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic
institutions and delivering quality diagnostic information to physicians and their patients worldwide, as well as proprietary products
that serve laboratories worldwide. Through its collaborations with world-class academic institutions specializing in cancer research,
diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. For more
information, please visit www.precipiodx.com.
on LinkedIn, Twitter @PrecipioDx and on Facebook.
Forward-Looking Statements
This press release contains "forward-looking
statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended, including, among others, statements related to the expected or potential impact of the novel coronavirus
(COVID-19) pandemic, and the related responses of the government, consumers, and the company, on our business, financial condition and
results of operations, and any such forward-looking statements, whether concerning the COVID-19 pandemic or otherwise, involve risks,
assumptions and uncertainties. Except for historical information, statements about future volumes, sales, growth, costs, cost savings,
margins, earnings, earnings per share, diluted earnings per share, cash flows, plans, objectives, expectations, growth or profitability
are forward-looking statements based on management's estimates, beliefs, assumptions and projections. Words such as "could,"
"may," "expects," "anticipates," "will," "targets," "goals," "projects,"
"intends," "plans," "believes," "seeks," "estimates," "predicts,"
and variations on such words, and similar expressions that reflect our current views with respect to future events and operational, economic
and financial performance, are intended to identify such forward-looking statements. These forward-looking statements are only predictions,
subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect
performance and cause results to differ materially from management's expectations, or could affect the company's ability to
achieve its strategic goals, include the uncertainties relating to the impact of COVID-19 on the company's business, operations
and employees and the other factors that are described in the sections entitled "Risk Factors" and "Management's
Discussion and Analysis" in the company's Annual Report on Form 10-K for the fiscal year ended December 31, 2021, as updated
from time to time in the company's Securities and Exchange Commission filings.
The company's forward-looking statements
in this press release are based on management's current views, beliefs, assumptions and expectations regarding future events and
speak only as of the date of this release. The company undertakes no obligation to publicly update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise, except as required by the federal securities laws.
Last updated: Nov 4, 2022